Over 100 fall ill after eating panipuris, all stable now

Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone

Supreme Court Upholds , FDA Regulation on Popular , Abortion Drug Mifepristone. On June 13, the Supreme Court ruled against a group of doctors who challenged the Food and Drug Administration's (FDA) regulations on the abortion pill mifepristone. CBS reports that the case once again highlighted abortion access following the conservative majority decision to overturn Roe v. Wade in 2022. The court ruled unanimously that the group of anti-abortion rights doctors and medical associations lacked the legal right to challenge the FDA. . However, the court also did not address whether the FDA's decision to relax the rules for mifepristone's use were lawful. . The latest ruling was authored by Justice Brett Kavanaugh. . Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish standing to sue. , Justice Brett Kavanaugh writing for the court, via CBS. Nor do the plaintiffs' other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA's actions, Justice Brett Kavanaugh writing for the court, via CBS. CBS reports that the ruling does not impact other challenges to the FDA's standing on mifepristone, while preserving access to the popular abortion medication. In 2016 and 2021, the FDA took steps to widen access to mifepristone, which has been taken by over 5 million patients since first being approved in 2000. Those steps included allowing the drug to be taken up to 10 weeks into a pregnancy, reducing the number of in-person doctor visits and permitting it to be sold through the mail.

Microdose Chocolate May Cause Seizures, FDA Warns

Microdose Chocolate , May Cause Seizures, FDA Warns. The FDA says that several people in four states have gotten sick after eating Diamond Shruumz chocolate bars. Severe symptoms experienced by the victims include "seizures, central nervous system depression, agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting," CBS News reports. . The chocolate, which is sold across the country, landed six of the eight victims in the hospital. . The company's website says that the chocolate is manufactured with a "primo proprietary blend of nootropic and functional mushrooms.". In 2022, the FDA called nootropics "a term widely used to market unapproved products as 'smart drugs' and 'cognitive enhancers.'". On June 7, the FDA warned parents to keep their kids away from the chocolate which is marketed as candy. . Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid this product being consumed by younger people. , FDA, via statement. Half of the victims were in Arizona, CBS News reports. . While these products claim to contain only natural ingredients and no scheduled drugs, there is clearly something toxic occurring, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release. We've seen the same phenomenon of people eating the chocolate bar then seizing, losing consciousness, and having to be intubated, Steve Dudley, director of the Arizona Poison and Drug Information Center, via news release

FDA Reverses Ban on Juul E-Cigarettes

FDA Reverses Ban , on Juul E-Cigarettes. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. On June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. NBC reports that the FDA first ordered Juul to take its product off the market in 2022, however the e-cigarettes have remained on shelves pending the company's appeal. In that time, Juul has maintained its position as the second-most popular e-cigarette in the U.S. The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . The FDA noted that reversing the ban temporarily was not an indication that the company's product would be ultimately cleared. . Sales of alternative nicotine products, like e-cigarettes, have continued to grow in the past decade. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . In 2023, the Centers for Disease Control and Prevention reported that e-cigarette use had grown by almost 50% between 2020 and 2022. . Juul released a statement following the FDA reversal, . ... saying the company looks forward to "re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization.". We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health, Juul statement, via NBC. 'The Wall Street Journal' reports that Juul has argued that the 2022 ban significantly disrupted the company's finances, resulting in an investor bailout. Currently, the FDA has only granted approval for 23 e-cigarette products, manufactured by only three companies, to be marketed and sold to consumers

FDA Reviewing Data on MDMA for Potential Approval of Groundbreaking PTSD Treatment

FDA Reviewing Data on MDMA , for Potential Approval of , Groundbreaking PTSD Treatment. 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). 'The Independent' reports that federal health advisers are considering a first-ever approval of MDMA, a psychedelic drug, to treat post traumatic stress disorder (PTSD). The news comes after decades of psychedelic advocates urging regulators to give the drug medical acceptance. . On June 4, the Food and Drug Administration (FDA) called on a group of outside experts to review the latest MDMA research. . The research suggests that when the drug is paired with talk therapy, it can help alleviate PTSD. . However, regulators at the FDA have questioned the reliability of the data, as well as the potential safety risks, which include possible heart problems and addiction. FDA approval could open the door for federal approval to be granted as soon as this summer. . Approval would make MDMA, often referred to as ecstasy or molly, the first illegal psychedelic to receive approval for mainstream medicine. . 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. 'The Independent' reports that a number of psychedelics are expected to receive FDA reviews in the coming years amid interest in their potential to treat depression, anxiety and addiction. It’s clear that MDMA-assisted therapy would be a welcome addition to the currently available options, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'. I’ve seen firsthand how this treatment can be lifesaving for some, Dr. Kelley O'Donnell, a New York University psychiatrist who helped conduct the MDMA studies, via 'The Independent'